Economical and Evidence Based “A Single Test Procedure” for Diagnosing GDM is Likely to be Globally Relevant

In pregnant women, an OGTT is performed by measuring plasma glucose in fasting or non-fasting conditions after ingesting 75 grammes of glucose for 2 hours (Monohydrate Dextrose Anhydrous). The Indian Guidelines (DIPSI Test) for detecting gestational diabetes (GDM) are straightforward. In low-resource situations when many pregnant women arrive for ANC check-ups, they can be completed rapidly. The severity of GDM worsens as Insulin action is reduced (insulin resistance) as a result of increased hormone release by the placenta. Other risk factors for GDM include being elderly, having a high BMI or obesity, gaining weight during pregnancy, having a family history of diabetes, having a stillbirth, or having a congenital defect in the past. deliveries. GDM was once thought to be temporary during pregnancy and would go away afterward, however pregnant women with hyperglycemia are more likely to acquire GDM in subsequent pregnancies. Within five to 10 years following delivery, around half of women with a history of GDM would develop type II diabetes. The National Health Mission (GOI) Guideline on GDM endorses the DIPSI basic testing methodology, which is also recommended by the FIGO guideline on the HIP for use in South Asia. Sri Lanka, Pakistan, and India have all followed this testing process. in the region, as well as Bangladesh. In 2007, Tamil Nadu and Uttar Pradesh, India, developed a Universal GDM Program, which covers all pregnancies by testing and controlling GDM with MNT, Metformin, and Insulin in most health care institutions. Around 28,000 ANM have been handed glucometers, strips, and glucose 75 gm packages to help administer Uttar Pradesh’s largest GDM programme.

Author (S) Details

Rajesh Jain
Gestational Diabetes Prevention Control Project, Maternal health, National Health Mission, Lucknow, India.

Seshiah
Consultants Dr. Balaji Diabetes Care Centre and Research Institute, Chennai, Tamilnadu, India.

Susanne Olejas
World Diabetes Foundation, Copenhagen, Denmark.

Bhavatharinin
S. R. C. Diabetes Care Centre, Erode, India.

Ashish S. Dengra
Department of Medicine, Mahi Diabetes Thyroid Care & Research Centre, Jabalpur, India.

Reza Shoghli
Department of Cardiology, Tehran heart center, Azad University of Tehran, Central Branch, Iran.

Sanjeev Davey
Department of Community Medicine, Muzaffarnagar Medical College, Muzaffarnagar, India.

Rachna Jain
Department of Obstetrics & Gynecology, Jain Hospital, Kanpur, India.

View Book :- https://stm.bookpi.org/NFMMR-V14/article/view/3387

Leave a Reply

Your email address will not be published.

Previous post Balantidium coli Presence in Human Urine Sample: A Mere Coincidence or More
Next post Determination of Diabetes and Dyslipidemia Goals in the Management of Diabetes